Propagation of a species requires periodic cell renewal to avoid clonal senescence. Liu et al. (2010) now describe a new mechanism of cell renewal in budding yeast, in which damaged protein aggregates are transported out of the daughter buds along actin cables to preserve youthfulness.
Neuronal damage after an acute brain insult, such as stroke and brain trauma, remains a major cause of morbidity and mortality worldwide and affects millions of lives every year. However, effective treatments remain lacking, which makes the identification of new therapeutic targets a matter of great importance. In this issue of Cell, Tu et al. identify DAPK1 (death-associated protein kinase 1) as a key component of a neuronal death signaling cascade downstream of NMDA (N-methyl-D-aspartate) glutamate receptors that mediates excitotoxic/ischemic brain damage after stroke. They provide convincing evidence that DAPK1 may be a target for the development of effective neuroprotectants.
The NMDA receptor (NMDAR) is a subtype of calcium-permeable ionotropic glutamate receptors that mediate fast synaptic transmission at the vast majority of excitatory synapses in the mammalian brain. Molecular cloning has thus far identified a number of NMDAR subunits classified into three subfamilies: NR1, NR2 (A-D), and NR3 (A and B). Most native NMDARs are tetrameric complexes consisting of two essential NR1 subunits and one or more regulatory NR2 subunits, most commonly NR2A and/or NR2B. NMDARs have important roles in synaptic physiology, including synaptic plasticity. However, during pathological conditions such as after stroke and brain trauma, NMDARs are excessively activated by an uncontrolled increase in the concentration of extracellular glutamate, resulting in increased Ca 2+ influx and neuronal death (Lipton and Rosenberg, 1994) . Recent studies (Hardingham et al., 2002; Liu et al., 2007) Blocking the Deadly Effects of the NMDA Receptor in Stroke Henry G.S. Martin 1 and Yu Tian Wang 1, * Figure 1 . Countering Excitoxicity Mediated by the NMDA Receptor (A) Under basal synaptic transmission, activation of synaptic (predominantly NR2A-containing) NMDA receptors (NMDAR) stimulates a neuronal survival signaling complex (SSC), promoting neuronal survival (Hardingham et al., 2002; Liu et al., 2007) . (B) After stroke, the increased extracellular concentration of glutamate causes overflow of synaptic glutamate and the excitotoxic activation of extrasynaptic (predominantly NR2B-containing) NMDARs (Hardingham et al., 2002; Liu et al., 2007) . The increase in Ca 2+ influx through NR2B-containing NMDARs activates DAPK and sequentially promotes the active DAPK (aDAPK) to bind and phosphorylated NR2B (Tu et al., 2010) . aDAPK recruitment then promotes the activation of a neuronal death signaling complex (DSC) that in turn shuts off the synaptic SSC activity (Hardingham et al., 2002) , and promotes neuronal death. (C) Application of NR2B-derived interference peptide (NR2B CT ) inhibits the binding of aDAPK to NR2B and blocks phosphorylation of the receptor. Loss of the interaction between aDAPK and NR2B reduces activation of DSC and because of this averts the excitotoxic neuronal damage induced by stroke (Tu et al., 2010) . For simplicity, NR2B-containing synaptic and NR2A-containing extrasynaptic NMDA receptors are omitted from the figure. suggest that a preferential activation of synaptically localized NMDARs, which predominantly contain NR2A (Tovar and Westbrook, 2002; Liu et al., 2007) , have a prosurvival role via activation of a neuronal survival signaling complex that is coupled to these receptors. In contrast, activation of extrasynaptic NMDARs, which predominantly contain NR2B (Tovar and Westbrook, 2002; Liu et al., 2007) , may have a cell death-inducing role through stimulation of a neuronal death signaling complex (Figure 1 ).
Despite promise in preclinical animal models, clinical trials for direct antagonism of the NMDAR as a stroke therapeutic have been disappointing, perhaps because of interference with physiological NMDAR function or a narrow therapeutic window. However, emerging evidence suggests that these problems might be circumvented by selectively targeting molecular components of the death signaling cascade downstream of NR2B-containing NMDARs (Aarts et al., 2002; Taghibiglou et al., 2009) . In this issue, Tu and colleagues used coimmunoprecipitation with NR2B-spcific antibodies and mass spectrometry to identify new signaling molecules engaged in the neuronal death cascade. They discover that after stroke insult, the NMDAR complex interacts with DAPK1, a member of a serine/threonine kinase family well known for their roles in cell death (Bialik and Kimchi, 2006 ).
The authors demonstrate that DAPK1 directly interacts with the NMDAR via an interaction in the carboxyl tail region of the NR2B subunit. By defining the exact binding domain of DAPK1 in NR2B, the authors are able to design an interference peptide (NR2B CT ; Figure 1 ) that effectively disrupts the interaction of DAPK1 with NMDARs during stroke. Using a cell line expression system, the authors find that only constitutively active DAPK1 is able to interact with NR2B and potentiate currents gated through the NR2B-(but not NR2A-) containing NMDARs. Importantly, the interference peptide effectively blocks both the association of DAPK1 with NR2B and the potentiation of NMDAR function. The authors then identified a single serine residue (Ser-1303) within the DAPK1 binding domain of NR2B that shows increased phosphorylation with DAPK1 activation.
Mutation of this site eliminates the ability of active DAPK1 to potentiate NMDAR currents, suggesting that the phosphorylation is critical to the DAPK1 response. It is worth noting that the authors do not show direct evidence of DAPK1 phosphorylation of Ser-1303; thus, the initial phosphorylation event may be due to other kinases downstream of DAPK1.
These findings suggest that the DAPK1-NR2B interaction may have a role in neuronal injury after excitotoxic and ischemic insults. Therefore, to examine whether DAPK1 activation plays a causative role in neuronal damage, the authors generated a DAPK1 knockout mice. Mice lacking DAPK1 are viable, and basal synaptic signaling and function appear to be unaffected. Using neuronal cultures deprived of oxygen and glucose to activate DAPK1, the authors noted an increase in currents and calcium transients gated through extrasynaptic (but not synaptic) NMDARs. This increase is not observed in neurons from mice lacking DAPK1, demonstrating that the potentiation by DAPK1 is specific to NR2B-containing NMDARs. In both the culture model and models of stroke in vivo, neuronal death is reduced in the absence of DAPK1. These results clearly demonstrate a critical role of DAPK1 in mediating neuronal damage after ischemia.
To demonstrate whether the association of DAPK1 with NR2B is responsible for the ischemic neuronal damage, the authors made a variant of the NR2B CT peptide that is membrane permeable. Remarkably, systemic injection of NR2B CT specifically blocks the association with and phosphorylation of the NR2B subunit by DAPK1 after transient focal ischemia, and markedly reduces infarct size compared to animals treated with a control peptide ( Figure 1C ). It is important to note that the neuroprotective effects of NR2B CT are effective even when given 60 min after stroke and are not associated with a general alteration in the activity and amount of DAPK1 in these treated animals. These results not only provide evidence that the formation of the DAPK1-NR2B complex is an essential step in cell death signaling cascades downstream of NMDARs, but also suggest that agents that disrupt the association between DAPK1 and NR2B may represent a new class of neuroprotective therapeutics against stroke (Figure 1 ).
There are several important questions arising from this study for future research. For instance, how is active DAPK1 recruited to the NR2B subunit? One possibility proposed by the authors is that DAPK1 may be activated by a calcinurin-mediated dephosphorylation of the kinase after excessive activation of the receptors that contain NR2B. Hypothetically, the resulting conformational change may then lead to the exposure of the NR2B binding region, presumably within the enzymatic region of DAPK1. It is interesting to note that Ser-1303 and the surrounding residues of NR2B required for DAPK1 binding have also previously been identified as a binding site for CaMKII, a calcium/calmodulin dependent kinase (Strack et al., 2000) . Under basal conditions, CaMKII is bound to the NR2B subunit at the region surrounding Ser-1303 in its dephosphorylated state. However upon calcium influx, Ser-1303 is phosphorylated, causing CaMKII to slowly dissociate from the site. It is important for future work to clarify how CaMKII-mediated phosphorylation and binding of NR2B affects DAPK1 association with and phosphorylation of NR2B. It is worth noting that Tu et al. do not observe a change in the quantity of CaM-KII associated with the NMDA receptor in response to stroke or following the application of NR2B CT . However, the activated CaMKII may remain within the NR2B complex via an alternative NR2B site as proposed by a previous study (Bayer et al., 2001 ).
Future research is also important to determine how DAPK1 binding to NR2B induces cell death. The authors present data suggesting that the binding is upstream of c-Jun N-terminal protein kinase (JNK) activation, an important step previously implicated in induction of neuronal death, but whether this is a consequence of DAPK1-dependent potentiation of NR2B-containing NMDARs or direct activation of the neuronal death signaling cascade is unclear. It is worth noting that specific antagonists of NR2B-containing NMDAR have shown little promise as a poststroke therapeutic, suggesting that changes in channel con-ductance may not be critical in neuronal death at a later stage of stroke (Liu et al., 2007) . Furthermore, a number of studies have identified other signaling components downstream of NR2B required for excitotoxic/ischemia induced neuronal death, such as neuronal nitric oxide synthase (Aarts et al., 2002) and SREPB1 (Taghibiglou et al., 2009) , and it will be important to identify how these tie into the findings of Tu et al.
Finally, it will also be interesting to explore the role of DAPK1 under physiological conditions. Its strong neuronal expression and localization in the postsynapse suggest a role in synaptic function yet to be discovered. Either way, the findings of Tu et al., along with several other studies (Aarts et al., 2002; Taghibiglou et al., 2009) , support the concept that targeting cell death signaling downstream of NMDARs is an effective neuroprotective strategy. In this regard, we very much share the hope with the authors that their discoveries might lead to new effective treatments for stroke.
The separation of germ cells from the soma potentiates the propagation of a species that lacks senescence, because new mechanisms emerge to preserve youthfulness in the specialized germ cells (Weisman, 1892) . In contrast, somatic cells age, at least in part, because they lack these mechanisms. The budding yeast provides a conceptual analog of the germ cell/somatic cell demarcation, because cells divide asymmetrically to give a young daughter cell that arises from the bud (the germ cell analog) and a mother cell that grows older with each budding event (the somatic cell analog). Studies by the Nystrom lab have shown that damaged protein aggregates accumulate in aging mother cells, but not in their daughters (Aguilaniu et al., 2003) . Now, in this issue, Liu et al. (2010) uncover an exciting new mechanistic basis for this asymmetry. They show that these damaged protein aggregates undergo retrograde transport along actin cables out of the growing bud and into the mother cell (Figure 1) .
The path leading to this discovery was based on this group's earlier finding that the asymmetric segregation of damaged proteins between mother and daughter cells required the anti-aging gene SIR2. This gene encodes an NAD-dependent deacetylase that retards aging in organisms ranging from yeast to mammals (Finkel et al., 2009) . In their new work, Liu et al. (2010) looked for new SIR2 functions using synthetic gene arrays (Tong et al., 2004) to identify genes that are required for survival of sir2 yeast mutants. Not surprisingly, one major category of genes was involved in the maintenance of chromatin. Less expected was the large number of genes involved in actinrelated cellular processes, including genes that encode components of the polarisome (Moseley and Goode, 2006) . The polarisome is a structure located at the distal end of the yeast bud that forms a focal point for polymerization of actin monomers into cables that extend from the bud tip to the mother cell ( Figure  1 ). These actin cables transport cargo from mother to daughter cell to support bud growth. This genetic association between a gene encoding a polarisome component and SIR2 is specific as no such interactions were observed for the yeast SIR2 paralogue, HST2.
The authors identify a likely mechanistic link between Sir2p and the polarisome by analyzing actin itself. In sir2 mutant strains, there is a substantial amount of unfolded actin monomers. In addition,
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